FTC splits again on dialysis merger
In another party-line vote, the Federal Trade Commission has approved the merger of two kidney disease treatment companies on the condition they divest a bloodline tubing business.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10